Here, we hypothesized that CIB1 may be associated with metabolic reprogramming in PDAC and may thus affect the TME via modulating tumor and stromal cellular components and immune cells to establish an immunosuppressive TME. The gene discussed is CIB1; the disease is neoplasm.